
National Children's Hospital used Macaques to test the effects of myostatin blocking on primates. The result: Muscular Monkeys
Get muscles now, ask me how. As published in the journal Science Translational Medicine, researchers at the National Children’s Hospital (NCH) and Ohio State University have proven that blocking myostatin in monkeys will lead to skeletal muscle growth with few or no discernible negative side effects. Myostatin is the protein that helps mammals regulate muscle building, acting as a signal for muscles to stop consuming resources and stop growing. Blocking myostatin leads to enhanced muscle strength and continuous muscle growth. You may remember Liam Hoekstra, the baby apparently born without the myostatin gene, and similarly enabled animals that have absurd strength. Using gene therapy, NCH scientists were able to get follistatin (a myostatin blocker) to promote phenomenal muscle growth in the quadriceps of macaque monkeys. NCH is now working with the FDA to perform the preliminary steps necessary for a human clinical trial. We could see a superman gene therapy available in the next decade.
The National Children’s Hospital interest in myostatin is not to create super strong children, but to help those children whose muscles have already atrophied. Muscular Dystrophy (MD) affects thousands of children in the US who slowly lose muscle and rarely survive into adulthood. Follistatin gene therapy could serve as a method to extend their lives or perhaps even reverse the symptoms of their conditions. Likewise, the eldery are susceptible to several diseases that lead to a loss of muscle strength and coordination. By blocking myostatin, we may all be able to live with the strength of our youth even as we age into our 80s.






32 Comments